Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
21.04
4.02
19.11%
Share Warrants & Outstandings
Total Reserve
300.97
173.75
127.22
73.22%
Shareholder's Funds
326.02
194.79
131.23
67.37%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.86
-0.86
-100.00%
Secured Loans
0.00
0.82
-0.82
-100.00%
Unsecured Loans
0.00
0.04
-0.04
-100.00%
Deferred Tax Assets / Liabilities
-2.08
0.89
-2.97
-333.71%
Other Long Term Liabilities
0.06
1.44
-1.38
-95.83%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
0.00
2.03
0.00%
Total Non-Current Liabilities
0.01
3.19
-3.18
-99.69%
Current Liabilities
Trade Payables
156.84
18.48
138.36
748.70%
Other Current Liabilities
11.00
11.26
-0.26
-2.31%
Short Term Borrowings
10.50
0.65
9.85
1,515.38%
Short Term Provisions
0.17
0.00
0.17
0.00%
Total Current Liabilities
178.51
30.39
148.12
487.40%
Total Liabilities
504.55
228.37
276.18
120.94%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
88.77
22.29
25.11%
Less: Accumulated Depreciation
61.36
40.78
20.58
50.47%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
47.99
1.71
3.56%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
12.77
-12.50
-97.89%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
0.00
51.95
0.00%
Long Term Loans & Advances
2.64
11.69
-9.05
-77.42%
Other Non Current Assets
15.30
1.57
13.73
874.52%
Total Non-Current Assets
128.38
74.02
54.36
73.44%
Current Assets Loans & Advances
Current Investments
53.86
0.00
53.86
0.00%
Inventories
74.48
33.63
40.85
121.47%
Sundry Debtors
215.87
64.88
150.99
232.72%
Cash and Bank
19.74
51.02
-31.28
-61.31%
Other Current Assets
11.48
0.69
10.79
1,563.77%
Short Term Loans and Advances
0.75
4.15
-3.40
-81.93%
Total Current Assets
376.17
154.36
221.81
143.70%
Net Current Assets (Including Current Investments)
197.66
123.96
73.70
59.45%
Total Current Assets Excluding Current Investments
322.31
154.36
167.95
108.80%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
228.37
276.18
120.94%
Contingent Liabilities
25.26
4.62
20.64
446.75%
Total Debt
10.50
1.51
8.99
595.36%
Book Value per share (adjusted)
32.53
87.56
-55.03
-62.85%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024






